<?xml version="1.0" encoding="UTF-8"?>
<p>The potency of the three inhibitors identified in the TLC bioautography was later determined with help of an image processing software, and in relation to galantamine, which is currently a commonly used plant derived drug registered for the treatment of Alzheimer’s disease. Both galantamine and the three candidates exhibit the same mechanism of action—they are all acetylcholinesterase inhibitors.</p>
